NEW YORK, Oct. 7, 2019 /PRNewswire/ —
There are numerous companies developing immunotherapy approaches to treat cancer, autoimmune and several other diseases.Current study describes some of the recent advances in immunotherapy, mostly cancer.
Read the full report: https://www.reportlinker.com/p05821889/?utm_source=PRN
These include refined cell therapies, stem cell applications in cancer treatment, monoclonal, polyclonal and bispecific antibodies.Some of exciting technologies like trispecific and multispecific fusion proteins and antibody derivatives are also covered.
Combination of various immunotherpy approaches with / without modification and some of the unique approaches like photoimmunotherapy, RNA therapy, synthetic oncolytic viruses and latest artificial intelligence based platforms to develop neoantigens, peptide vaccines are discussed.
Read the full report: https://www.reportlinker.com/p05821889/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
WASHINGTON – Today, the U.S. Department of the Treasury (Treasury), as Chair of the Committee…
WASHINGTON—Today, the U.S. Department of the Treasury’s Community Development Financial Institutions Fund (CDFI Fund) and…
Washington – The findings from the annual survey of U.S. portfolio holdings of foreign securities…
WASHINGTON – The U.S. Department of the Treasury hosted a roundtable on October 30 with…
WASHINGTON – The United States and the People’s Republic of China held the sixth meeting…
WASHINGTON — Today, the Department of the Treasury’s Office of Foreign Assets Control (OFAC) sanctioned…